Inovio Pharmaceuticals Inc (INO)

[mackwheaton]

I do think we see a 4 for 1 split as soon as they can and a move to $10-$12 ($2.50-$3 pre RS) immediately. Good phase II data jumps us to $20 then, and it will still be a steal at that PPS .

They can't afford to wait to do the RS, only because, if by chance Phase II data hits a snag, doing the RS after looks desperate and hurts cred.